A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.
Also called NCT06979375
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT06979375 -
jRCT2031250305
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Australia, Czechia, Germany, India, Japan, Netherlands, Poland, South Korea, Spain, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT06979375. Randomized; quadruple masking; primary purpose treatment. Start 2025-06-30 (actual); primary completion 2027-05-16 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy
- Acronym
- 8282-Reduced
- Condition
- Heart Failure
- Intervention (Drug)
- CDR132L
- Intervention (Drug)
- Placebo
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct06979375- Content hash
912bbbb3d90ef6b1c9b38bd83c3ba6b4f247c938fd04101c1c497ab7dac67389